Sexual Dysfunction, Depression, and the Impact of Antidepressants

被引:238
作者
Kennedy, Sidney H. [1 ,2 ]
Rizvi, Sakina [2 ,3 ,4 ]
机构
[1] Univ Toronto, Dept Psychiat, Toronto, ON M5G 2C4, Canada
[2] Univ Hlth Network, Dept Psychiat, Toronto, ON M5G 2C4, Canada
[3] Univ Toronto, Dept Pharmaceut Sci, Toronto, ON M5G 2C4, Canada
[4] Univ Toronto, Dept Neurosci, Toronto, ON M5G 2C4, Canada
关键词
sexual dysfunction; SSRI; antidepressant; major depressive disorder; agomelatine; SEROTONIN-REUPTAKE INHIBITORS; TREATMENT-RESISTANT DEPRESSION; PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; MAJOR DEPRESSION; BRAIN ACTIVATION; ERECTILE DYSFUNCTION; EXTENDED-RELEASE; VENLAFAXINE XR; PARALLEL-GROUP;
D O I
10.1097/JCP.0b013e31819c76e9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Sexual dysfunction is a common symptom of depression. Although decreased libido is most often reported, difficulties with arousal, resulting in vaginal dryness in women and erectile dysfunction in men, and absent or delayed orgasm are also prevalent. Sexual dysfunction is also a frequent adverse effect of treatment with most antidepressants and is one of the predominant reasons for premature drug discontinuation. Selective serotonin reuptake inhibitors are the most widely prescribed anti depressants and have significant effects on arousal and orgasm compared with antidepressants that target norepinephrine, dopamine, and melatonin systems. The availability of an antidepressant that does not cause or exacerbate sexual dysfunction represents an advance in pharmacotherapy for mood disorders and should reduce treatment noncompliance and decrease the need for switching antidepressants or adding antidotes. The purpose of this review was to provide an update on the prevalence, psychobiology, and relative adverse effect burden of sexual dysfunction associated with different antidepressants.
引用
收藏
页码:157 / 164
页数:8
相关论文
共 117 条
[1]   Lithium and male sexual function in affective patients [J].
Aizenberg, D ;
Sigler, M ;
Zemishlany, Z ;
Weizman, A .
CLINICAL NEUROPHARMACOLOGY, 1996, 19 (06) :515-519
[2]  
Akpafflong MJ, 2008, GERIATRICS-US, V63, P18
[4]   The relationship between depressive symptoms and male erectile dysfunction: Cross-sectional results from the Massachusetts Male Aging Study [J].
Araujo, AB ;
Durante, R ;
Feldman, HA ;
Goldstein, I ;
McKinlay, JB .
PSYCHOSOMATIC MEDICINE, 1998, 60 (04) :458-465
[5]   Resolution of sexual dysfunction during double-blind treatment of major depression with reboxetine or paroxetine [J].
Baldwin, D ;
Bridgman, K ;
Buis, C .
JOURNAL OF PSYCHOPHARMACOLOGY, 2006, 20 (01) :91-96
[6]   Resolution of sexual dysfunction during acute treatment of major depression with milnacipran [J].
Baldwin, David ;
More, Ricardo A. ;
Brlley, Mike .
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2008, 23 (06) :527-532
[7]   Selective serotonin re-uptake inhibitor treatment-emergent sexual dysfunction: randomized double-blind placebo-controlled parallel-group fixed-dose study of a potential adjuvant compound, VML-670 [J].
Baldwin, David ;
Hutchison, John ;
Donaldson, Kirsteen ;
Shaw, Bob ;
Smithers, Andrew .
JOURNAL OF PSYCHOPHARMACOLOGY, 2008, 22 (01) :55-63
[8]   A double-blind, randomized, parallel-group, flexible-dose study to evaluate the tolerability, efficacy and effects of treatment discontinuation with escitalopram and paroxetine in patients with major depressive disorder [J].
Baldwin, DS ;
Cooper, JA ;
Huusom, AKT ;
Hindmarch, I .
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2006, 21 (03) :159-169
[9]   Depression and sexual dysfunction [J].
Baldwin, DS .
BRITISH MEDICAL BULLETIN, 2001, 57 :81-99
[10]  
Baldwin DS, 1996, J PSYCHOPHARMACOL, V10, P30